Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Couples Dynamics and Smoking Cessation (SCOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03885336
Recruitment Status : Recruiting
First Posted : March 21, 2019
Last Update Posted : April 28, 2021
Sponsor:
Collaborator:
American Cancer Society, Inc.
Information provided by (Responsible Party):
Matthew Kirkpatrick, University of Southern California

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study is about investigating smoking and attempts to quit smoking in couples. Participation will help determine better treatment efforts for couples who want to quit smoking. All study procedures will be conducted remotely, allowing couples to interact with study personnel through zoom.

Condition or disease Intervention/treatment
Smoking Smoking Cessation Cessation, Smoking Smoking Behaviors Smoking, Cigarette Other: No Interventions

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interpersonal Mechanisms of Smoking Relapse in Romantic Couples
Actual Study Start Date : August 26, 2018
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Smoking

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Both-Quit Group
Couples in which both individuals smoke and both individuals would like to quit smoking.
 Other: No Interventions
There are no interventions in this study. Participants are observed.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Cigarette Craving [ Time Frame: Throughout study completion, an average of 28 days ]
    This measure is obtained through the completion of the Brief Questionnaire of Smoking Urges.

  2. Confidence in Quit Attempt [ Time Frame: Throughout study completion, an average of 28 days ]
    This measure is obtained through the completion of the Abstinence Self-Efficacy Questionnaire.

  3. Mood [ Time Frame: Throughout study completion, an average of 28 days ]
    This measure is obtained through the completion of the Profile of Mood States Questionnaire.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants may live through the United States.
Criteria

Inclusion Criteria:

  • Couples must be in a relationship for more than 6 months with no plans to separate or move in the next 30 days.
  • Participants must smoke at least 5 cigarettes per day for at least the past 2 years.

Exclusion Criteria:

  • English non-fluency.
  • Currently pregnant, nursing, or intend to become pregnant within the next 6 months.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03885336


Contacts
Layout table for location contacts
Contact: Patrick Loftus 323-442-2277 ploftus@usc.edu

Locations
Layout table for location information
United States, California
University of Southern California Recruiting
Los Angeles, California, United States, 90033
Contact: Patrick Loftus    323-442-2277    ploftus@usc.edu   
Principal Investigator: Matthew Kirkpatrick, PhD         
Sponsors and Collaborators
University of Southern California
American Cancer Society, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Matthew Kirkpatrick, PhD University of Southern California
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Matthew Kirkpatrick, Assistant Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT03885336    
Other Study ID Numbers: HS-16-00898
First Posted: March 21, 2019    Key Record Dates
Last Update Posted: April 28, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No